Multi-modality Echocardiography for Cardiac Assessment in Primary Electrical Disease
- Conditions
- Primary Electrical DiseaseMulti-modality Echocardiography
- Interventions
- Diagnostic Test: Echocardiography
- Registration Number
- NCT06172842
- Brief Summary
From 2020 to 2023, patients with primary electrical disease (idiopathic ventricular fibrillation, long QT syndrome, Andersen-Tawil syndrome type I, Brugada syndrome, early repolarization syndrome, CPVT, and short QT syndrome) were first diagnosed at Sun Yat-sen Memorial Hospital of Sun Yat-sen University, and clinical data and echocardiographic indicators were recorded. Follow-up is until December 30, 2025 or endpoint event occurs. Endpoint events were defined as sustained ventricular tachycardia, ventricular fibrillation, sudden cardiac death, ICD discharge events, all-cause death, heart failure and heart transplantation, which were statistically analyzed as a composite endpoint of cardiovascular analysis. The predictors of primary electrical disease and the risk factors for adverse cardiovascular events were analyzed.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 30
- primary electrical disease
- Congenital heart disease, poor echocardiographic images, moderate or severe valvular disease
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description primary electrical disease Echocardiography - control Echocardiography -
- Primary Outcome Measures
Name Time Method Multi-modality echocardiography 2 years tissue Doppler imging, speckle-tracking-strain, myocardial work, mechanical dispersion,electro-mechanical window
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Hanlu Lv
🇨🇳Guangzhou, China